3Roujeau JC, Stem RS. Severe adverse cutaneous reactions to drugs.N Engl J Med 1994;331 : 1272 - 1285.
4Kumar A, Teuber SS,Gershwin ME. Intravenous immunoglobulin: striving for appropriate use. Int Arch Allergy Immunol 2006; 140: 185 - 198.
5Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD35 with human intravenous immunoglobulin. Science 1998; 282: 490 - 493.
6Bachot N, Revuz J, Roujeau JC. Intravenous immtmoglobulin treatment for Stevens - Johnson Syndrome and toxic epidermal necrolysis. Arch Dermatol 2003; 139:33 - 36.
